Predictors of dementia misclassification when using brief cognitive assessments
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received May 30, 2018
- Accepted September 17, 2018
- First Published November 28, 2018.
Article Versions
- Previous version (November 28, 2018 - 12:45).
- You are viewing the most recent version of this article.
Author Disclosures
- Janice M. Ranson, MSc,
- Elżbieta Kuźma, PhD,
- William Hamilton, MD,
- Graciela Muniz-Terrera, PhD,
- Kenneth M. Langa, MD, PhD and
- David J. Llewellyn, PhD
- Janice M. Ranson, MSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Elżbieta Kuźma, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1)Halpin Trust(2) James Tudor Foundation(3) Wellcome Trust ISSF Seed Corn Fund(4) Mary Kinross Charitable Trust
NONE
NONE
NONE
NONE
NONE
NONE
- William Hamilton, MD,
NONE
NONE
NONE
Family Practice (Oxford), Associate Editor, since 2007
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
1. Policy Research Unit in Cancer Awareness, Screening and Early Diagnosis, Department of Health. ?4,997,576.00 [co- applicant, and early diagnosis lead] 2018-2023. 2.Understanding the effectiveness, cost-effectiveness and current use of cancer diagnostic tools to aid decision- making in primary care. HTA ?240,800. [co-applicant] 2017-8 3. 'WICKED? (Wales Interventions and Cancer Knowledge about Early Diagnosis): The development and evaluation of primary care interventions to expedite the diagnosis of symptomatic cancer in Wales. Welsh Govt ?800,000, 2016-8. [co-applicant] 4. Clinical and cost effectiveness of progressive exercise compared to best practice advice, with or without corticosteroid injection, for the treatment of rotator cuff disorders: a 2x2 factorial randomized controlled trial (GRASP). NIHR HTA ?1,228,000 2016-9.
NONE
1. What is the clinical-effectiveness and cost-effectiveness of embedded risk-of-cancer assessment of patients in primary care; the ERICA trial. W Hamilton, M Pitt, Anne Spencer, John Campbell, Rod Taylor, G Abel & F Warren, and S Dean. ?2.75m Philanthropic donation to University of Exeter, D and M Gillings, 2018-2020 [principal applicant] 2.Selection of Eligible People for Lung Cancer Screening using Electronic Primary Care DaTa: Development of new risk prediction models. Baldwin, D, O?Dowd, E, Hubbard, R, de Koning, H, Field, J, Hamilton, W, Callister, M, ten Haaf, K, Janes, S. CRUK. 2018-2021, ?352,945. [co-applicant] 3. Enhancing the diagnostic pathway for dementia: The DECODE Project. Llewellyn D,Ballard, C, Campbell, J, Hamilton W, Dean D, Kuzma, E, Moore, S, Warren, F, Lang I. The Halpin Trust. ?123,558. 2018-2020. 4. Guideline discordant diagnostic care: when do primary care referrals not reflect guidelines for suspected cancer. Abel G, Lyratzopoulos, G, Campbell, J, Hamilton W. CRUK, ?117.089. 2018-9. [co-applicant] 5. CanTest- Cancer diagnostic testing in primary care: a paradigm shift for cancer diagnosis. Hamilton W, Walter F (co-PIs), Johnson, M, Singh, H, Lyratzopoulos, G, Abel, G, Spencer, A, Thompson, M, Sutton, S, Rubin, G, Neal R, Vedsted, P, Emery J. CRUK Catalyst Award, ?4,834,829. 2017- 22. [co-PI]
NONE
NONE
NONE
NONE
NONE
NONE
- Graciela Muniz-Terrera, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Kenneth M. Langa, MD, PhD and
NONE
NONE
University of Pennsylvania, honorarium for lecture
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) NIA U01 AG009740, Co-I, 2007-2018;
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- David J. Llewellyn, PhD
NONE
NONE
(1) Roche, conference travel, (2) DSM, workshop travel and speaker honorarium.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Mary Kinross Charitable Trust, (2) Alzheimer?s Society, (3) U.S. National Institute on Aging, (4) Wellcome Trust Institutional Strategic Support Award (internal), (5) Health Foundation, (6) Halpin Trust, (7) James Tudor Foundation, (8) National Institute on Aging (R01 AG055654-01A1), (9) JP Moulton Foundation
NONE
NONE
NONE
NONE
NONE
NONE
- From the University of Exeter Medical School (J.M.R., E.K., W.H., D.J.L.); Centre for Dementia Prevention, University of Edinburgh (G.M.-T.), United Kingdom; The Alan Turing Institute (D.J.L.), London, United Kingdom; and Medical School (K.M.L.), Institute for Social Research, Institute for Healthcare Policy and Innovation, Veterans Affairs Ann Arbor Healthcare System, University of Michigan.
- Correspondence
Dr. Llewellyn david.llewellyn{at}exeter.ac.uk
Article usage
Cited By...
The Nerve!: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Sevil Yaşar and Dr. Behnam Sabayan
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Article
Cumulative Genetic Risk and APOE ε4 Are Independently Associated With Dementia Status in a Multiethnic, Population-Based CohortKelly M. Bakulski, Harita S. Vadari, Jessica D. Faul et al.Neurology: Genetics, March 05, 2021 -
Articles
Relative preservation of MMSE scores in autopsy-proven dementia with Lewy bodiesP. T. Nelson, R. J. Kryscio, G. A. Jicha et al.Neurology, October 05, 2009 -
Articles
Prevalence of cognitive impairmentData from the Indianapolis Study of Health and AgingF. W. Unverzagt, S. Gao, O. Baiyewu et al.Neurology, November 13, 2001 -
Articles
Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson diseaseS. Hoops, S. Nazem, A. D. Siderowf et al.Neurology, November 23, 2009